Navigation Links
Chronic pain up almost 40 percent among US workers in past decade

Persistent, chronic pain has risen dramatically among full-time U.S. workers in the past 10 years, but workers today opt to go to their jobs rather than call in sick, leading to a growing trend of presenteeism ?a negative impact on work despite being physically present at the job. These data, released today, are from a 2006 national survey conducted by Harris Interactive® on "Pain in the Workplace" (www.painandwork.com), sponsored by PriCaraÔ, Unit of Ortho-McNeil, Inc., and conducted in partnership with the National Pain Foundation (NPF). The survey was an update to the 1996 Louis Harris & Associates poll on the subject, sponsored by Ortho-McNeil Pharmaceutical, Inc.

"Chronic pain appears to be increasing in prevalence among U.S. workers as Americans age and lead more sedentary lifestyles," said Rollin Gallagher, M.D., M.P.H., editor-in-chief of the NPF Web site (www.NationalPainFoundation.org), a founding and current member of the Board of the NPF and clinical professor and director, Center for Pain Medicine, Research and Policy of the University of Pennsylvania. "This survey indicates that employees with chronic pain must become their own advocates, understand the impact of their chronic pain and work with their healthcare provider to identify appropriate treatment options."

Chronic pain, defined in the survey as pain that lasts for at least six months, was more common in the workplace in 2006 than it was in 1996 (26 percent vs. 19 percent).

Today, almost nine in 10 employees with chronic pain (89 percent) typically go to work rather than stay home when experiencing chronic pain, the survey found. The same percentage of employees (89 percent) reported experiencing chronic pain at work "often" or "sometimes." Ninety-five percent of employees with persistent, chronic pain reported that their pain must be moderately severe or very severe to c
'"/>

Source:Ruder Finn Public Relations


Page: 1 2

Related biology news :

1. FDA Clears the Way for Generic Versions of Transdermal Patches to Treat Chronic Pain
2. Chronic Sinus Infection Thought To Be Tissue Issue, Mayo Clinic Scientists Show Its Snot
3. FDA Approves New Treatment for Chronic Hepatitis B
4. Chronic jet-lag conditions hasten death in aged mice
5. Chronic fatigue syndrome impairs a persons slow wave activity during sleep
6. Farm kids almost twice as likely to die from injury as children overall
7. Hunger in America rises by 43 percent over last five years
8. Method slashes quantum dot costs by 80 percent
9. Hepatitis B accounts for 40 percent of missing Asian women
10. Vaccine provides 100 percent protection against avian flu virus in animal study
11. Oceans are 70 percent shark free
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chronic pain almost percent among workers past decade

(Date:12/11/2014)... Minn. , Dec. 10, 2014  Data ... physiologic monitoring, has released a new series of ... of preclinical toxicology researchers. M series, part of ... toxicologists collect the best possible physiologic data when ... Adding functional endpoints to toxicology studies has ...
(Date:12/10/2014)... , Dec. 08, 2014 Research and Markets ... addition of the "Biometrics Market in Japan ... http://photos.prnewswire.com/prnh/20130307/600769 The ... such as rural banking and upgradation of the ... witnessed in the market. Besides the aforementioned projects, ...
(Date:12/3/2014)... Dec. 2, 2014   Marvin Test Solutions ... test solutions for military, aerospace, and manufacturing organizations, ... its successful TS-900 PXI semiconductor test platform ... of high-end systems to customers at a fraction ... to traditional ATE. "Our semiconductor ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... New Rochelle, NY, April 3, 2009A novel technique ... challenge the market dominance of the current, widely ... News ( GEN ). Some scientists believe ... for gene-expression analysis, will eventually rival microarrays in ...
... the 82-ton-force, earthquake-simulation shake table could not knock down ... Nevada, Reno alumna and civil engineer Darcey Donovan. ... foundation and clay plaster walls, the way she builds ... acceleration/shaking than was recorded at the 1994 Northridge, Calif. ...
... allergy may be malfunction of the respiratory epithelium, which ... the epithelium. Two studies by Finnish research groups on ... biomedical journals (1) Allergy , and (2) ... Research on the mechanisms of allergy has focused on ...
Cached Biology News:Straw bale house survives violent shaking at earthquake lab 2Straw bale house survives violent shaking at earthquake lab 3Malfunction of the respiratory epithelium is a cause of allergy? 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... on gynecologic disease, today announced the next step in ... premier bio-analytics solutions provider with the naming of current ... and Chief Executive Officer, while current Chairman of the ... to serve as Chairman. These changes are effective January ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel ... (NASDAQ: BCLI ), a leading developer of ... that wholly-owned subsidiary Brainstorm Cell Therapeutics Ltd. was awarded ... Israel,s Office of the Chief Scientist (OCS).  ... in receipt of grant support from the Office of ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... trend toward miniaturization, carbon nanotubes which are about ... several unique and very useful properties have become ... nanosized electronic and mechanical devices. But it is precisely ... clump together, that make it difficult for scientists to ...
... and ... excellent value, BOSTON, May ... and medical image and information management solutions,today announced that it has ... use MEDITECH(TM) as their health,information system. AMICAS will be showcasing Vision ...
... industry to benefit ... recruitment efforts, MINNEAPOLIS, May 27 Leading ... strengthened the,pharmaceutical side of its business with the ... commitment to leveraging differentiators unique,to the medical device ...
Cached Biology Technology:Weizmann Institute scientists create new nanotube structures 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 2AMICAS Announces Integrations at More Than 100 MEDITECH Facilities 3ThreeWire Expands Presence in the Pharmaceutical Arena 2